Jiangsu Bioperfectus Technologies Co (SHSE:688399) Piotroski F-Score: 4 (As of Jul. 20, 2026) — 20% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688399 Jiangsu Bioperfectus Technologies Co Ltd SHSE:688399
63 GF Score
Price ¥30.33
GF Value ¥28.95
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Jiangsu Bioperfectus Technologies Co Piotroski F-Score?

Jiangsu Bioperfectus Technologies Co SHSE:688399 -3.71% 63 Piotroski F-Score is 4 as of Jul. 20, 2026, which is 20% below its 10-year median of 5.00. GuruFocus rates SHSE:688399 with a GF Score™ of 63/100 and a GF Value™ of ¥28.95 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,334 Biotechnology companies, Jiangsu Bioperfectus Technologies Co ranks better than 74.06% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Jiangsu Bioperfectus Technologies Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Jiangsu Bioperfectus Technologies Co's Piotroski F-Score or its related term are showing as below:

SHSE:688399' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 7
Current: 4

During the past 10 years, the highest Piotroski F-Score of Jiangsu Bioperfectus Technologies Co was 7. The lowest was 2. And the median was 5.

Jiangsu Bioperfectus Technologies Co  (SHSE:688399) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Jiangsu Bioperfectus Technologies Co Piotroski F-Score Related Terms


Jiangsu Bioperfectus Technologies Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Jiangsu Bioperfectus Technologies Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Bioperfectus Technologies Co Piotroski F-Score Chart

Jiangsu Bioperfectus Technologies Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 7.00 5.00 5.00 5.00

Jiangsu Bioperfectus Technologies Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 4.00 4.00 5.00 4.00

SHSE:688399 vs VRTX, REGN, ALNY: Piotroski F-Score Comparison

For the Biotechnology subindustry, Jiangsu Bioperfectus Technologies Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Bioperfectus Technologies Co Piotroski F-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jiangsu Bioperfectus Technologies Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Jiangsu Bioperfectus Technologies Co's Piotroski F-Score falls into.


SHSE:688399
63GF Score
Jiangsu Bioperfectus Technologies Co Ltd SHSE:688399
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -8.827 + -0.841 + -44.23 + 21.122 = ¥-32.8 Mil.
Cash Flow from Operations was -4.843 + 20.001 + 10.916 + -2.648 = ¥23.4 Mil.
Revenue was 83.972 + 81.927 + 81.54 + 78.584 = ¥326.0 Mil.
Gross Profit was 56.565 + 53.144 + 51.351 + 46.142 = ¥207.2 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(3869.325 + 3880.968 + 3648.633 + 3554.351 + 3664.206) / 5 = ¥3723.4966 Mil.
Total Assets at the begining of this year (Mar25) was ¥3,869.3 Mil.
Long-Term Debt & Capital Lease Obligation was ¥77.0 Mil.
Total Current Assets was ¥1,795.2 Mil.
Total Current Liabilities was ¥539.9 Mil.
Net Income was -10.827 + -2.126 + -29.116 + 12.819 = ¥-29.3 Mil.

Revenue was 86.329 + 90.64 + 81.521 + 91.608 = ¥350.1 Mil.
Gross Profit was 56.267 + 55.133 + 41.626 + 53.069 = ¥206.1 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(4033.25 + 4004.213 + 3856.867 + 3739.948 + 3869.325) / 5 = ¥3900.7206 Mil.
Total Assets at the begining of last year (Mar24) was ¥4,033.3 Mil.
Long-Term Debt & Capital Lease Obligation was ¥9.7 Mil.
Total Current Assets was ¥2,133.3 Mil.
Total Current Liabilities was ¥485.0 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Jiangsu Bioperfectus Technologies Co's current Net Income (TTM) was -32.8. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Jiangsu Bioperfectus Technologies Co's current Cash Flow from Operations (TTM) was 23.4. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-32.776/3869.325
=-0.00847073

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-29.25/4033.25
=-0.00725222

Jiangsu Bioperfectus Technologies Co's return on assets of this year was -0.00847073. Jiangsu Bioperfectus Technologies Co's return on assets of last year was -0.00725222. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Jiangsu Bioperfectus Technologies Co's current Net Income (TTM) was -32.8. Jiangsu Bioperfectus Technologies Co's current Cash Flow from Operations (TTM) was 23.4. ==> 23.4 > -32.8 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=77.038/3723.4966
=0.02068969

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=9.713/3900.7206
=0.00249005

Jiangsu Bioperfectus Technologies Co's gearing of this year was 0.02068969. Jiangsu Bioperfectus Technologies Co's gearing of last year was 0.00249005. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=1795.205/539.903
=3.32505098

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=2133.253/484.995
=4.39850514

Jiangsu Bioperfectus Technologies Co's current ratio of this year was 3.32505098. Jiangsu Bioperfectus Technologies Co's current ratio of last year was 4.39850514. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Jiangsu Bioperfectus Technologies Co's number of shares in issue this year was 125.044. Jiangsu Bioperfectus Technologies Co's number of shares in issue last year was 126.485. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=207.202/326.023
=0.63554412

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=206.095/350.098
=0.58867803

Jiangsu Bioperfectus Technologies Co's gross margin of this year was 0.63554412. Jiangsu Bioperfectus Technologies Co's gross margin of last year was 0.58867803. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=326.023/3869.325
=0.08425837

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=350.098/4033.25
=0.08680295

Jiangsu Bioperfectus Technologies Co's asset turnover of this year was 0.08425837. Jiangsu Bioperfectus Technologies Co's asset turnover of last year was 0.08680295. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+0+0+1+1+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Jiangsu Bioperfectus Technologies Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
Jiangsu Bioperfectus Technologies Co (SHSE:688399) has a Piotroski F-Score of 4 as of Jul. 20, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Jiangsu Bioperfectus Technologies Co and its competitors. This is 20% below median its historical median of 5.00. Over the past decade, Jiangsu Bioperfectus Technologies Co's Piotroski F-Score has ranged from 2.00 to 7.00. According to the industry distribution chart, Jiangsu Bioperfectus Technologies Co ranks #346 out of 1334 companies in the Biotechnology industry, placing it in the top 25.9%.
Is Jiangsu Bioperfectus Technologies Co's Piotroski F-Score too high?
Jiangsu Bioperfectus Technologies Co's current Piotroski F-Score of 4 is 20% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 7.00. The Biotechnology industry median Piotroski F-Score is 3.00. Jiangsu Bioperfectus Technologies Co's value of 4 is 33.3% above this industry median. Based on the distribution chart, Jiangsu Bioperfectus Technologies Co ranks #346 out of 1334 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Jiangsu Bioperfectus Technologies Co has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Bioperfectus Technologies Co's Piotroski F-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Jiangsu Bioperfectus Technologies Co ranks #346 out of 1334 companies for Piotroski F-Score. This puts Jiangsu Bioperfectus Technologies Co in the upper half of its industry. The industry median Piotroski F-Score is 3.00. Jiangsu Bioperfectus Technologies Co's value of 4 is 33.3% above this benchmark. Historically, Jiangsu Bioperfectus Technologies Co's own Piotroski F-Score has ranged from 2.00 to 7.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 3.00, Jiangsu Bioperfectus Technologies Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Biotechnology company?
The median Piotroski F-Score among Biotechnology companies is 3.00, based on 1,334 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangsu Bioperfectus Technologies Co's current Piotroski F-Score of 4 is 33.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Jiangsu Bioperfectus Technologies Co and its competitors. For the Biotechnology industry, the median Piotroski F-Score is 3.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangsu Bioperfectus Technologies Co's current Piotroski F-Score is 4, which is 20% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Bioperfectus Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Bioperfectus Technologies Co (SHSE:688399) is currently considered Fairly Valued. The stock's GF Value™ is ¥28.95, compared to a current price of ¥30.33 — trading 4.8% above its estimated fair value. The current Piotroski F-Score is 4, which is 20% below median its 10-year median of 5.00 and 33.3% above the Biotechnology industry median of 3.00. Jiangsu Bioperfectus Technologies Co's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Jiangsu Bioperfectus Technologies Co (SHSE:688399), the current Piotroski F-Score is 4 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangsu Bioperfectus Technologies Co (SHSE:688399) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Bioperfectus Technologies Co stock appears to be overvalued. The current stock price of ¥30.33 is trading 4.8% above its estimated GF Value™ of ¥28.95. GuruFocus considers Jiangsu Bioperfectus Technologies Co to be Fairly Valued.

Key valuation signals for SHSE:688399:

  • Piotroski F-Score: 4 (20% below median its 10-year median of 5.00)
  • GF Value™: ¥28.95 vs. price of ¥30.33 (4.8% above fair value)
  • GF Score™: 63/100 with 4 warning signs
  • Industry Position: 33.3% above the Biotechnology median (#346 of 1334)

No single metric tells the full story. See the SHSE:688399 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jiangsu Bioperfectus Technologies Co Business Description

Address 3rd floor, Block G19, No.1 Yaocheng Avenue, Jiangsu, Taizhou, CHN
Jiangsu Bioperfectus Technologies Co Ltd is engaged in product development, production and sales of disease prevention and control, female genital micro-ecological testing and tumor screening. Its products portfolio includes Fever respiratory pathogen detection series, Fever with a rash pathogen test series, Fever with bleeding pathogen test series, Foodborne diseases and diarrheal pathogen detection and Other types of pathogen detection series.
63GF Score

Get the complete analysis for SHSE:688399

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥30.33
Price
¥28.95
GF Value